LOGIN  |  REGISTER
Assertio
Assertio

Dynatronics Announces Participation in Investor Conferences

March 02, 2023 | Last Trade: US$0.12 0.00 0.00
  • Canaccord Genuity 2023 Musculoskeletal Conference: March 7, 2023
  • Roth Capital Conference: March 12 - 14, 2023
  • Investor Summit: March 29, 2023

Eagan, Minnesota--(Newsfile Corp. - March 2, 2023) - Dynatronics Corporation (NASDAQ: DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that management will participate in three investor conferences in March 2023, to provide an update on the company's business.

John Krier, President and CEO of Dynatronics Corporation, will participate in the Canaccord Genuity 2023 Musculoskeletal Conference on March 7, 2023, held in Las Vegas, and will also participate in the Roth Capital Conference on March 12 - 14, 2023, held in Dana Point, California. Mr. Krier will also join the Investor Summit being held virtually on March 29, 2023. Management will be available for one-on-one meetings and will present in a group format at each of these conferences. Investors interested in scheduling one-on-one meetings are encouraged to register online, through the individual conference platforms. The presentations for the conferences can be found on the company's investor relations page at https://www.dynatronics.com/investors/.

About Dynatronics Corporation

Dynatronics Corporation is a leading medical device company committed to providing high-quality restorative products designed to accelerate achieving optimal health. The company designs, manufactures, and sells a broad range of products for clinical use in physical therapy, rehabilitation, pain management, and athletic training. Through its distribution channels, Dynatronics markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and consumers. The company's products are marketed under a portfolio of high-quality, well-known industry brands including Bird & Cronin®, Dynatron Solaris®, Hausmann™, Physician's Choice®, and PROTEAM™, among others. More information is available at www.dynatronics.com.

Investor Contacts:

Dynatronics Corporation
Investor Relations
This email address is being protected from spambots. You need JavaScript enabled to view it.

For additional information, please visit: www.dynatronics.com.

Connect with Dynatronics on LinkedIn.

C4 Therapeutics

Stock Quote

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB